STERIS (NYSE:STE) CFO Karen Burton Sells 5,880 Shares of Company Stock

STERIS plc (NYSE:STE) CFO Karen Burton sold 5,880 shares of STERIS stock in a transaction on Wednesday, November 11th. The shares were sold at an average price of $255.62, for a total transaction of $1,503,045.60. Following the completion of the transaction, the chief financial officer owned 12,956 shares in the company, valued at approximately $3,311,812.72. This trade represents a 31.22% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

STERIS Trading Down 1.1%

Shares of NYSE STE traded down $2.77 during trading on Thursday, hitting $253.50. 503,989 shares of the company traded hands, compared to its average volume of 773,021. The firm has a market capitalization of $24.62 billion, a P/E ratio of 30.07 and a beta of 0.86. The company has a quick ratio of 1.44, a current ratio of 2.05 and a debt-to-equity ratio of 0.23. The company has a 50-day moving average price of $222.09 and a 200-day moving average price of $224.66. STERIS plc has a 1 year low of $195.14 and a 1 year high of $269.44.

STERIS (NYSE:STE) last posted its quarterly earnings results on Wednesday, November 4th. The medical equipment provider reported $2.94 EPS for the quarter, beating the consensus estimate of $2.68 by $0.26. The firm had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.56 billion. STERIS had a net margin of 13.41% and a return on equity of 14.80%. STERIS’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter last year, the firm posted $2.47 earnings per share. On average, equities analysts predict that STERIS plc will post 11.46 EPS for the current year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Tuesday, November 17th will be paid a $0.69 dividend. This represents a $2.76 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Tuesday, November 17th. STERIS’s payout ratio is 32.74%.

Wall Street Analysts Forecast Growth

STE has been the topic of several research analyst reports. Piper Sandler reaffirmed an “overweight” rating and set a $275.00 price target (up from $270.00) on shares of STERIS in a research report on Friday, August 7th. KeyCorp lifted their target price on STERIS from $269.00 to $284.00 and gave the stock an “overweight” rating in a research report on Friday, November 6th. UBS Group lowered their price target on STERIS from $275.00 to $270.00 and set a “buy” rating for the company in a report on Friday, August 7th. Wall Street Zen lowered STERIS from a “strong-buy” rating to a “buy” rating in a research report on Sunday, October 11th. Finally, Weiss Ratings upgraded STERIS from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday. Three research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $276.33.

Hedge Funds Weigh In On STERIS

Several institutional investors have recently made changes to their positions in STE. Wellington Management Group LLP lifted its holdings in shares of STERIS by 21.9% in the 2nd quarter. Wellington Management Group LLP now owns 3,502,897 shares of the medical equipment provider’s stock worth $737,605,000 after purchasing an additional 629,532 shares during the last quarter. Janus Henderson Group PLC grew its stake in STERIS by 25.7% during the 1st quarter. Janus Henderson Group PLC now owns 1,863,139 shares of the medical equipment provider’s stock worth $411,995,000 after buying an additional 380,504 shares during the last quarter. Amundi increased its position in STERIS by 43.2% in the first quarter. Amundi now owns 771,092 shares of the medical equipment provider’s stock worth $170,512,000 after buying an additional 232,520 shares during the period. SEB Asset Management AB acquired a new stake in STERIS in the first quarter worth $30,660,000. Finally, Hsbc Holdings PLC lifted its stake in STERIS by 352.5% in the first quarter. Hsbc Holdings PLC now owns 176,320 shares of the medical equipment provider’s stock valued at $38,958,000 after buying an additional 137,355 shares during the last quarter. 94.69% of the stock is owned by institutional investors.

STERIS Company Profile

STERIS plc (NYSE: STE) provides infection prevention and procedural products and services for healthcare, pharmaceutical, research, and other industries. Its offerings include sterilizers, washers and other equipment used to clean and sterilize medical devices and surgical instruments, as well as products for operating rooms and endoscopy procedures. The company also provides equipment installation, maintenance, repair, and training, along with contract sterilization and laboratory testing services.